Ritonavir 100mg tabs/PAC-30 pb

General Description
Ritonavir 100mg film coated, heat stable tablets, bottle pack of 30.

Technical Specifications
Each film coated tablet contains Ritonavir 100mg in a heat stable formulation.

Therapeutic class
Ritonavir is a protease inhibitor (PI)

Standard shelf life
24 Months

Other available formulations
The product may also be available in other formulations, pack sizes, or in combinations with other ARVs.

Guidelines for use
For more details, please see WHO treatment guidelines http://www.who.int/hiv/pub/guidelines/en/index.html and WHO Essential Medicines Library http://www.who.int/emlib/ or your regional/national guidelines.

Details about paediatric dosage schemes can be found at http://www.who.int/hiv/topics/paediatric/en/index.html

WHO generic tool for assessing paediatric ARV dosing
http://www.who.int/hiv/paediatric/generictool/en/

Indications
Management of HIV-1 infection in children and adults as a booster to increase effect of Darunavir, Indinavir, Lopinavir or Saquinavir and in additional combination with two other antiretroviral drugs. By mouth (oral) PO.

Packaging and storage
Do not store above 25ºC (77°F), protect from light.
Store in tightly closed original container.
Keep out of reach and sight of children.

Dispensing instructions
Dispense in original container. Do not repack.

Regulatory Status
For latest updates check the list of ‘Prequalified Medicines’ on the WHO website ‘Prequalification Programme’. http://apps.who.int/prequal/

For latest updates check the list of ‘USFDA approved and tentatively approved’ items on the USFDA website. http://www.fda.gov/default.htm, http://www.accessdata.fda.gov/Scripts/cder/DrugsatFDA/